ST
PBYI icon

Spot Trading’s Puma Biotechnology PBYI Stock Holding History

Spot Trading’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-17,400
Closed -$534K – 3231
2016
Q4 		$534K Buy
+17,400
New +$752K 0.01% 1375
2016
Q1 		– Sell
-1,600
Closed -$125K – 3821
2015
Q4 		$125K Sell
1,600
-4,400
-73% -$345K ﹤0.01% 2713
2015
Q3 		$452K Buy
6,000
+800
+15% +$75.7K ﹤0.01% 2122
2015
Q2 		$607K Buy
5,200
+4,900
+1,633% +$887K 0.01% 1980
2015
Q1 		$71K Sell
300
-100
-25% -$21.4K ﹤0.01% 3211
2014
Q4 		$76K Buy
+400
New +$88.7K ﹤0.01% 3326
2014
Q3 		– Sell
-500
Closed -$33K – 4627
2014
Q2 		$33K Buy
+500
New +$35.6K ﹤0.01% 4041

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Spot Trading's PBYI Position: Q1 2017 in Review

Spot Trading sold out of Puma Biotechnology (PBYI) in Q1 2017, closing a stake of 9,521 shares — an estimated $292K sold.

Spot Trading first reported a position in PBYI in Q2 2014 and held it in 7 quarters. The position peaked at $317K in Q2 2015. 136 funds tracked by Wall St. Rank hold PBYI as of Q1 2017.

  • Spot Trading reported no remaining Puma Biotechnology position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 9,521 Puma Biotechnology shares in Q1 2017, an estimated $292K.
  • Spot Trading first reported a position in Puma Biotechnology in Q2 2014 and held it in 7 quarters.
  • Spot Trading's Puma Biotechnology position peaked at $317K in Q2 2015.
  • 136 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.